Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy

Stroke

Volumn 42, Issue 11, 2011, Pages 3047-3054

  Han, Jay S ^a,b   Abou Hamden, Amal ^c   Mandell, Daniel M ^d   Poublanc, Julien ^d   Crawley, Adrian P ^d   Fisher, Joseph A ^a   Mikulis, David J ^d   Tymianski, Michael ^b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

cerebrovascular reactivity; EC IC bypass; hemodynamics; MR imaging; stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN ARTERY BYPASS; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; END TIDAL CARBON DIOXIDE TENSION; EXTRAINTRACRANIAL ANASTOMOSIS; FEMALE; FISHER EXACT TEST; FOLLOW UP; HEMISPHERE; HUMAN; HYPERCAPNIA; MALE; MIDDLE CEREBRAL ARTERY; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANKIN SCALE; STROKE; SUPERFICIAL TEMPORAL ARTERY; TREATMENT OUTCOME; WHITE MATTER;

ADOLESCENT; ADULT; AGED; CEREBRAL REVASCULARIZATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; MOYAMOYA DISEASE; PROSPECTIVE STUDIES; TEMPORAL ARTERIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054977414     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.615955     Document Type: Article

References (28)

1. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research committee on spontaneous occlusion of the circle of Willis (moyamoya disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99(suppl 2):S238-S240.
2. Zipfel GJ, Fox DJ Jr, Rivet DJ. Moyamoya disease in adults: the role of cerebral revascularization. Skull Base. 2005;15:27-41. (Pubitemid 40458299)
3. Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: A review of the literature. Childs Nerv Syst. 2005;21: 358-364. (Pubitemid 41372157)
4. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226-1237.
5. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC bypass study group. N Engl J Med. 1985;313:1191-1200.
6. Mandell DM, Han JS, Poublanc J, Crawley AP, Stainsby JA, Fisher JA, et al. Mapping cerebrovascular reactivity using blood oxygen leveldependent MRI in patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI. Stroke. 2008;39:2021-2028.
7. Gur AY, Bova I, Bornstein NM. Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients? Stroke. 1996;27: 2188-2190. (Pubitemid 26427190)
8. Silvestrini M, Vernieri F, Pasqualetti P, Matteis M, Passarelli F, Troisi E, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA. 2000;283:2122-2127. (Pubitemid 30241308)
9. Grubb RL Jr, Powers WJ, Derdeyn CP, Adams HP Jr, Clarke WR. The carotid occlusion surgery study. Neurosurg Focus. 2003;14:e9.
10. Rim NJ, Kim HS, Shin YS, Kim SY. Which ct perfusion parameter best reflects cerebrovascular reserve? Correlation of acetazolamidechallenged ct perfusion with single-photon emission ct in moyamoya patients. AJNR Am J Neuroradiol. 2008;29:1658-1663.
11. Heyn C, Poublanc J, Crawley A, Mandell D, Han JS, Tymianski M, et al. Quantification of cerebrovascular reactivity by blood oxygen leveldependent MR imaging and correlation with conventional angiography in patients with moyamoya disease. AJNR Am J Neuroradiol. 2010;31: 862-867.
12. Mikulis DJ, Krolczyk G, Desal H, Logan W, Deveber G, Dirks P, et al. Preoperative and postoperative mapping of cerebrovascular reactivity in moyamoya disease by using blood oxygen level-dependent magnetic resonance imaging. J Neurosurg. 2005;103:347-355. (Pubitemid 43193913)
13. Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A. 1990;87:9868-9872. (Pubitemid 120016545)
14. Slessarev M, Han J, Mardimae A, Prisman E, Preiss D, Volgyesi G, et al. Prospective targeting and control of end-tidal CO2 and O2 concentrations. J Physiol. 2007;581:1207-1219. (Pubitemid 46887989)
15. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29: 162-173. (Pubitemid 26266657)
16. Thines L, Agid R, Dehdashti AR, da Costa L, Wallace MC, Terbrugge KG, et al. Assessment of extracranial-intracranial bypass patency with 64-slice multidetector computerized tomography angiography. Neuroradiology. 2009;51:505-515.
17. Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in contemporary stroke trials. Int J Stroke. 2009;4:200-205.
18. Honda M, Ezaki Y, Kitagawa N, Tsutsumi K, Ogawa Y, Nagata I. Quantification of the regional cerebral blood flow and vascular reserve in moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography. Surg Neurol. 2006;66:155-159; discussion 159. (Pubitemid 44107428)
19. Andaluz N, Choutka O, Vagal A, Strunk R, Zuccarello M. Patient selection for revascularization procedures in adult moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA). Neurosurg Rev. 2010;33:225-232; discussion 232-233.
20. Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37:1490-1496. (Pubitemid 44305731)
21. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008;39:3193-3200.
22. Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg. 2009;111:927-935.
23. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke. 2007;38:1430-1435. (Pubitemid 46684140)
24. Kastrup A, Li TQ, Glover GH, Moseley ME. Cerebral blood flow-related signal changes during breath-holding. AJNR Am J Neuroradiol. 1999;20: 1233-1238. (Pubitemid 29400531)
25. Hamzei F, Knab R, Weiller C, Rother J. The influence of extra- and intracranial artery disease on the bold signal in fMRI. Neuroimage. 2003;20:1393-1399. (Pubitemid 37268156)
26. Wise RG, Pattinson KT, Bulte DP, Chiarelli PA, Mayhew SD, Balanos GM, et al. Dynamic forcing of end-tidal carbon dioxide and oxygen applied to functional magnetic resonance imaging. J Cereb Blood Flow Metab. 2007;27:1521-1532. (Pubitemid 47106610)
27. McAuley DJ, Poskitt K, Steinbok P. Predicting stroke risk in pediatric moyamoya disease with xenon-enhanced computed tomography. Neurosurgery. 2004;55:327-332; discussion 332-333. (Pubitemid 39014519)
28. Piao R, Oku N, Kitagawa K, Imaizumi M, Matsushita K, Yoshikawa T, et al. Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation. Ann Nucl Med. 2004;18:115-121. (Pubitemid 38856005)